Phospholipase A/Acyltransferase enzyme activity of H-rev107 inhibits the H-RAS signaling pathway

Journal of Biomedical Science

Volumn 21, Issue 1, 2014, Pages

  Wang, Chun Hua ^a   Shyu, Rong Yaun ^a,b   Wu, Chang Chieh ^c   Tsai, Tzung Chieh ^d   Wang, Lu Kai ^e   Chen, Mao Liang ^a   Jiang, Shun Yuan ^a   Tsai, Fu Ming ^a  

^a TAIPEI TZU CHI HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Acyl biotin exchange assay; H RAS; H rev107; HRASLS3; Phospholipase A acyltransferase; PLA2G16

Indexed keywords

ACYLTRANSFERASE; ARACHIDONYL TRIFLUOROMETHYL KETONE; BIOTIN; EPIDERMAL GROWTH FACTOR; FLUOROPHOSPHATE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PHOSPHOLIPASE A; PHOSPHOLIPID; TRANSCRIPTION FACTOR ELK 1; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; PHOSPHOLIPASE A2; PLA2G16 PROTEIN, HUMAN; SIGNAL PEPTIDE; TUMOR SUPPRESSOR PROTEIN;

ACYLATION; ARTICLE; CANCER CELL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENETIC TRANSDUCTION; H REV107 GENE; HUMAN; HUMAN CELL; ONCOGENE H RAS; PALMITOYLATION; PHOSPHOLIPID METABOLISM; PRECIPITATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEADY STATE; TRANSACTIVATION; TUMOR SUPPRESSOR GENE; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; ONCOGENE RAS;

ACYLTRANSFERASES; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; GENES, RAS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHOLIPASES A2; PHOSPHOLIPASES A2, CALCIUM-INDEPENDENT; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84900425099     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-21-36     Document Type: Article

References (49)

1. Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11-12. Husmann K, Sers C, Fietze E, Mincheva A, Lichter P, Schafer R, Oncogene 1998 17 1305 1312 10.1038/sj.onc.1202060 9771974 (Pubitemid 28446171)
2. Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells. Nazarenko I, Schafer R, Sers C, J Cell Sci 2007 120 1393 1404 10.1242/jcs.000018 17374643 (Pubitemid 46780032)
3. Identification and functional characterization of adipose-specific phospholipase A2 (AdPLA). Duncan RE, Sarkadi-Nagy E, Jaworski K, Ahmadian M, Sul HS, J Biol Chem 2008 283 25428 25436 10.1074/jbc.M804146200 18614531
4. Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts. Hajnal A, Klemenz R, Schafer R, Oncogene 1994 9 479 490 8290259 (Pubitemid 24041527)
5. Cloning and characterization of a novel retinoid-inducible gene 1(RIG1) deriving from human gastric cancer cells. Huang SL, Shyu RY, Yeh MY, Jiang SY, Mol Cell Endocrinol 2000 159 15 24 10.1016/S0303-7207(99)00207-5 10687848 (Pubitemid 30067636)
6. Characterization of the human tumor suppressors TIG3 and HRASLS2 as phospholipid-metabolizing enzymes. Uyama T, Jin XH, Tsuboi K, Tonai T, Ueda N, Biochim Biophys Acta 2009 1791 1114 1124 10.1016/j.bbalip.2009.07.001 19615464
7. Cloning and functional characterization of the HRASLS2 gene. Shyu RY, Hsieh YC, Tsai FM, Wu CC, Jiang SY, Amino Acids 2008 35 129 137 10.1007/s00726-007-0612-2 18163183
8. cDNA cloning and characterization of human and mouse Ca(2+)-independent phosphatidylethanolamine N-acyltransferases. Jin XH, Uyama T, Wang J, Okamoto Y, Tonai T, Ueda N, Biochim Biophys Acta 2009 1791 32 38 10.1016/j.bbalip.2008.09. 006 19000777
9. Molecular cloning and biological activity of a novel Ha-Ras suppressor gene predominantly expressed in skeletal muscle, heart, brain, and bone marrow by differential display using clonal mouse EC cells, ATDC5. Akiyama H, Hiraki Y, Noda M, Shigeno C, Ito H, Nakamura T, J Biol Chem 1999 274 32192 32197 10.1074/jbc.274.45.32192 10542256 (Pubitemid 29522960)
10. Isolation, characterization, and chromosome mapping of a human A-C1 Ha-Ras suppressor gene (HRASLS). Ito H, Akiyama H, Shigeno C, Nakamura T, Cytogenet Cell Genet 2001 93 36 39 10.1159/000056944 11474175 (Pubitemid 32727541)
11. Evolutionary history, structural features and biochemical diversity of the NlpC/P60 superfamily of enzymes. Anantharaman V, Aravind L, Genome Biol 2003 4 11 10.1186/gb-2003-4-2-r11 12620121
12. The 2A proteins of three diverse picornaviruses are related to each other and to the H-rev107 family of proteins involved in the control of cell proliferation. Hughes PJ, Stanway G, J Gen Virol 2000 81 201 207 10640559 (Pubitemid 30047923)
13. RIG1 inhibits the Ras/mitogen-activated protein kinase pathway by suppressing the activation of Ras. Tsai FM, Shyu RY, Jiang SY, Cell Signal 2006 18 349 358 10.1016/j.cellsig.2005.05.005 16005186 (Pubitemid 41661350)
14. Induction of apoptosis by the retinoid inducible growth regulator RIG1 depends on the NC motif in HtTA cervical cancer cells. Tsai FM, Shyu RY, Lin SC, Wu CC, Jiang SY, BMC Cell Biol 2009 10 15 10.1186/1471-2121-10-15 19245694
15. A novel tumor suppressor protein promotes keratinocyte terminal differentiation via activation of type I transglutaminase. Sturniolo MT, Dashti SR, Deucher A, Rorke EA, Broome AM, Chandraratna RA, Keepers T, Eckert RL, J Biol Chem 2003 278 48066 48073 10.1074/jbc.M307215200 12928434 (Pubitemid 37523257)
16. The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity. Deucher A, Nagpal S, Chandraratna RA, Di Sepio D, Robinson NA, Dashti SR, Eckert RL, Int J Oncol 2000 17 1195 1203 11078805
17. TIG3 interaction at the centrosome alters microtubule distribution and centrosome function. Scharadin TM, Jiang H, Martin S, Eckert RL, J Cell Sci 2012 125 2604 2614 10.1242/jcs.096495 22427689
18. TIG3 tumor suppressor-dependent organelle redistribution and apoptosis in skin cancer cells. Scharadin TM, Jiang H, Jans R, Rorke EA, Eckert RL, PLoS One 2011 6 23230 10.1371/journal.pone.0023230 21858038
19. RIG1 suppresses Ras activation and induces cellular apoptosis at the Golgi apparatus. Tsai FM, Shyu RY, Jiang SY, Cell Signal 2007 19 989 999 10.1016/j.cellsig.2006.11.005 17196792 (Pubitemid 46436438)
20. The retinoid-inducible gene I: effect on apoptosis and mitogen-activated kinase signal pathways. Huang SL, Shyu RY, Yeh MY, Jiang SY, Anticancer Res 2002 22 799 804 12014653
21. Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors. Sers C, Emmenegger U, Husmann K, Bucher K, Andres AC, Schafer R, J Cell Biol 1997 136 935 944 10.1083/jcb.136.4.935 9049257 (Pubitemid 27098748)
22. A novel transglutaminase activator forms a complex with type 1 transglutaminase. Sturniolo MT, Chandraratna RA, Eckert RL, Oncogene 2005 24 2963 2972 10.1038/sj.onc.1208392 15846304 (Pubitemid 40675527)
23. The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells. Sers C, Husmann K, Nazarenko I, Reich S, Wiechen K, Zhumabayeva B, Adhikari P, Schroder K, Gontarewicz A, Schafer R, Oncogene 2002 21 2829 2839 10.1038/sj.onc.1205377 11973642 (Pubitemid 34499380)
24. The tumor suppressor gene H-Rev107 functions as a novel Ca2 + -independent cytosolic phospholipase A1/2 of the thiol hydrolase type. Uyama T, Morishita J, Jin XH, Okamoto Y, Tsuboi K, Ueda N, J Lipid Res 2009 50 685 693 10.1194/jlr.M800453-JLR200 19047760
25. Enzymological analysis of the tumor suppressor A-C1 reveals a novel group of phospholipid-metabolizing enzymes. Shinohara N, Uyama T, Jin XH, Tsuboi K, Tonai T, Houchi H, Ueda N, J Lipid Res 2011 52 1927 1935 10.1194/jlr.M015081 21880860
26. Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus. Shih TY, Papageorge AG, Stokes PE, Weeks MO, Scolnick EM, Nature 1980 287 686 691 10.1038/287686a0 6253810 (Pubitemid 11216446)
27. Regulators and effectors of ras proteins. Bollag G, McCormick F, Annu Rev Cell Biol 1991 7 601 632 10.1146/annurev.cb.07.110191.003125 1667084
28. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Chardin P, Camonis JH, Gale NW, van Aelst L, Schlessinger J, Wigler MH, Bar-Sagi D, Science 1993 260 1338 1343 10.1126/science.8493579 8493579 (Pubitemid 23231980)
29. Regulating the regulator: post-translational modification of RAS. Ahearn IM, Haigis K, Bar-Sagi D, Philips MR, Nat Rev Mol Cell Biol 2012 13 39 51
30. The intracellular dynamic of protein palmitoylation. Salaun C, Greaves J, Chamberlain LH, J Biol Chem 2010 191 1229 1238
31. Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Choy E, Chiu VK, Silletti J, Feoktistov M, Morimoto T, Michaelson D, Ivanov IE, Philips MR, Cell 1999 98 69 80 10.1016/S0092-8674(00)80607-8 10412982 (Pubitemid 29331197)
32. An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Rocks O, Peyker A, Kahms M, Verveer PJ, Koerner C, Lumbierres M, Kuhlmann J, Waldmann H, Wittinghofer A, Bastiaens PI, Science 2005 307 1746 1752 10.1126/science.1105654 15705808 (Pubitemid 40388611)
33. Depalmitoylated Ras traffics to and from the Golgi complex via a nonvesicular pathway. Goodwin JS, Drake KR, Rogers C, Wright L, Lippincott-Schwartz J, Philips MR, Kenworthy AK, J Cell Biol 2005 170 261 272 10.1083/jcb.200502063 16027222 (Pubitemid 41043808)
34. Palmitoylated Ras proteins traffic through recycling endosomes to the plasma membrane during exocytosis. Misaki R, Morimatsu M, Uemura T, Waguri S, Miyoshi E, Taniguchi N, Matsuda M, Taguchi T, J Cell Biol 2010 191 23 29 10.1083/jcb.200911143 20876282
35. H-rev107 regulates prostaglandin D2 synthase-mediated suppression of cellular invasion in testicular cancer cells. Shyu RY, Wu CC, Wang CH, Tsai TC, Wang LK, Chen ML, Jiang SY, Tsai FM, J Biomed Sci 2013 20 30 10.1186/1423-0127-20-30 23687991
36. Global analysis of protein palmitoylation in yeast. Roth AF, Wan J, Bailey AO, Sun B, Kuchar JA, Green WN, Phinney BS, Yates JR 3rd, Davis NG, Cell 2006 125 1003 1013 10.1016/j.cell.2006.03.042 16751107 (Pubitemid 43795188)
37. Regulation of peroxisomal lipid metabolism by catalytic activity of tumor suppressor H-rev107. Uyama T, Ichi I, Kono N, Inoue A, Tsuboi K, Jin XH, Araki N, Aoki J, Arai H, Ueda N, J Biol Chem 2012 287 2706 2718 10.1074/jbc.M111. 267575 22134920
38. Palmitoylation: policing protein stability and traffic. Linder ME, Deschenes RJ, Nat Rev Mol Cell Biol 2007 8 74 84 10.1038/nrm2084 17183362 (Pubitemid 46012016)
39. Small-molecule inhibition of APT1 affects Ras localization and signaling. Dekker FJ, Rocks O, Vartak N, Menninger S, Hedberg C, Balamurugan R, Wetzel S, Renner S, Gerauer M, Scholermann B, Rusch M, Kramer JW, Rauh D, Coates GW, Brunsveld L, Bastiaens PI, Waldmann H, Nat Chem Biol 2010 6 449 456 10.1038/nchembio.362 20418879
40. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Dennis EA, Cao J, Hsu YH, Magrioti V, Kokotos G, Chem Rev 2011 111 6130 6185 10.1021/cr200085w 21910409
41. Inhibition of phospholipase A2. Gelb MH, Jain MK, Berg OG, FASEB J 1994 8 916 924 8088457 (Pubitemid 2156014)
42. The ABC's of Group IV cytosolic phospholipase A2. Lucas KK, Dennis EA, Biochim Biophys Acta 2004 1636 213 218 10.1016/j.bbalip.2003.12.009 15164769 (Pubitemid 38780798)
43. Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, Gross RW, J Biol Chem 2004 279 48968 48975 10.1074/jbc.M407841200 15364929 (Pubitemid 39625778)
44. Raft protein clustering alters N-Ras membrane interactions and activation pattern. Eisenberg S, Beckett AJ, Prior IA, Dekker FJ, Hedberg C, Waldmann H, Ehrlich M, Henis YI, Mol Cell Biol 2011 31 3938 3952 10.1128/MCB.05570-11 21807892
45. Protein localization: Can too much lipid glue stop Ras? Cox AD, Nat Chem Biol 2010 6 483 485 10.1038/nchembio.399 20559313
46. Involvement of the prostaglandin D2 signal pathway in retinoid-inducible gene 1 (RIG1)-mediated suppression of cell invasion in testis cancer cells. Wu CC, Shyu RY, Wang CH, Tsai TC, Wang LK, Chen ML, Jiang SY, Tsai FM, Biochim Biophys Acta 1823 2012 2227 2236
47. Analysis of the secretory phospholipase A2 that mediates prostaglandin production in mast cells. Reddy ST, Winstead MV, Tischfield JA, Herschman HR, J Biol Chem 1997 272 13591 13596 10.1074/jbc.272.21.13591 9153207 (Pubitemid 27224790)
48. Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Fujishima H, Sanchez Mejia RO, Bingham CO 3rd, Lam BK, Sapirstein A, Bonventre JV, Austen KF, Arm JP, Proc Natl Acad Sci U S A 1999 96 4803 4807 10.1073/pnas.96.9.4803 10220374 (Pubitemid 29214492)
49. H-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signaling. Nazarenko I, Kristiansen G, Fonfara S, Guenther R, Gieseler C, Kemmner W, Schafer R, Petersen I, Sers C, Am J Pathol 2006 169 1427 1439 10.2353/ajpath.2006.051341 17003497 (Pubitemid 351194375)